Unrecognized paroxysmal supraventricular tachycardia: Potential for misdiagnosis as panic disorder

Archives of Internal Medicine

Volumn 157, Issue 5, 1997, Pages 537-543

  Lessmeier, Timothy J ^c,d   Gamperling, Deborah ^a,b   Johnson Liddon, Vichi ^a,b   Fromm, Barbara S ^a   Steinman, Russell T ^a,b   Meissner, Marc D ^a   Lehmann, Michael H ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b Sinai Hospital   (United States)

^c Heart Clinics Northwest   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; FLECAINIDE ACETATE; PROCAINAMIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CATHETER ABLATION; CHILD; DIAGNOSTIC ERROR; ELECTROCARDIOGRAPHY; FEMALE; HEART PREEXCITATION; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; PANIC; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; REENTRY TACHYCARDIA; RETROSPECTIVE STUDY; SYMPTOMATOLOGY;

EID: 0031054806     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.5.537     Document Type: Article

References (48)

1. Goldreyer BN, Kastor JA, Kershbaum KL. The hemodynamic effects of induced supraventricular tachycardia in man. Circulation. 1976;54:783-789.
2. Bhandari AK, Anderson JL, Gilbert M, et al. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. Am Heart J. 1992;124:381-386.
3. Grossman DS, Cohen TJ, Goldner B, Jadonath R. Pseudorecurrence of paroxysmal supraventricular tachycardia after radiofrequency catheter ablation. Am Heart J. 1994;128:516-519.
4. Lau CP, Tai YT, Lee P. The effects of radiofrequency ablation versus medical therapy on the quality-of-life and exercise capacity in patients with accessory pathway-mediated supraventricular tachycardia: a treatment comparison study. Pacing Clin Electrophysiol. 1995;18:424-432.
5. Sintetos AL, Roark SF, Smith MS, McCarthy EA, Lee KL, Pritchett ELC. Incidence of symptomatic tachycardia in untreated patients with paroxysmal supraventricular tachycardia. Arch Intern Med. 1986;146:2205-2209.
6. Pritchett ELC, McCarthy EA, Lee KL. Clinical behavior of paroxysmal atrial tachycardia. Am J Cardiol. 1988;62(suppl):3D-9D.
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994:394-403.
8. Josephson ME. Supraventricular tachycardias. In: Josephson ME. Clinical Cardiac Electrophysiology. 2nd ed. Philadelphia, Pa: Lea & Febiger; 1993:181-274.
9. Wu D, Denes P, Amat-y-Leon F, et al. Clinical, electrocardiographic and electrophysiologic observations in patients with paroxysmal supraventricular tachycardia. Am J Cardiol. 1978;41:1045-1051.
10. Manolis AS, Estes M. Supraventricular tachycardia: mechanisms and therapy. Arch Intern Med. 1987;147:1706-1716.
11. Chen SA, Chiang CE, Tsang WP, et al. Selective radiofrequency catheter ablation of fast and slow pathways in 100 patients with atrioventricular nodal reentrant tachycardia. Am Heart J. 1993;125:1-10.
12. Jackman WM, Beckman KJ, McClelland JH, et al. Treatment of supraventricular tachycardia due to atrioventricular nodal reentry by radiofrequency catheter ablation of slow-pathway conduction. N Engl J Med. 1992;327:313-318.
13. Lesh MD, Van Hare GF, Schamp DJ, et al. Curative percutaneous catheter ablation using radiofrequency energy for accessory pathways in all locations: results in 100 consecutive patients. J Am Coll Cardiol. 1992;19:1303-1309.
14. Jazayeri M, Hempe S, Sra J, et al. Selective transcatheter ablation of the slow pathway for the treatment of atrioventricular nodal reentry tachycardia. Circulation. 1992;85:1318-1328.
15. Kay G, Epstein A, Dailey S, Plumb V. Selective radiofrequency ablation of the slow pathway for the treatment of atrioventricular nodal reentrant tachycardia. Circulation. 1992;85:1675-1688.
16. Jackman WM, Wang X, Friday KJ, et al. Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N Engl J Med. 1991;324:1605-1611.
17. Mann DE, Kelly PA, Adler SW, Fuenzalida CE, Reiter MJ. Palpitations occur frequently following radiofrequency ablation for supraventricular tachycardia, but do not predict pathway recurrence. J Am Coll Cardiol. 1993;21:356. Abstract.
18. Engelstein ED, Lippman N, Lerman BB. Significance of recurrent palpitations after successful radiofrequency ablation of accessory pathways. Circulation. 1992;86(suppl 1):1-580. Abstract.
19. Clair WK, Wilkinson WE, McCarthy EA, Page RL, Pritchett ELC. Spontaneous occurrence of symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia in untreated patients. Circulation, 1993;87:1114-1122.
20. Rodriguez LM, de Chillou C, Schlapfer J, et al. Age at onset and gender of patients with different types of supraventricular tachycardias. Am J Cardiol. 1992;70:1213-1215.
21. Katon W. Panic disorder and somatization: review of 55 cases. Am J Med. 1984;77:101-106.
22. Weissman MM, Epidemiology of panic disorder and agoraphobia. In: Ballenger JC, ed. Clinical Aspects of Panic Disorder. New York, NY: John Wiley & Sons Inc; 1990:57-66.
23. Matuzas W, Al-Sadir J, Uhlenhuth EH, Glass RM. Mitral valve prolapse and thyroid abnormalities in patients with panic attacks. Am J Psychiatry. 1987;144:493-496.
24. Sheehan DV, Ballenger J, Jacobson G. Treatment of endogenous anxiety with phobic, hysterical and hypochondriacal symptoms. Arch Gen Psychiatry. 1980;37:51-59.
25. Wellens HJJ, Bar FW, Farre J, et al. Diagnosis and incidence of concealed accessory pathways in patients suffering from paroxysmal AV junctional tachycardias. Rev Lat Cardiol. 1980;1:60-67.
26. Mitrani RD, Klein LS, Hackett FK, Zipes DP, Miles WM. Radiofrequency ablation for atrioventricular node reentrant tachycardia: comparison between fast (anterior) and slow (posterior) pathway ablation. J Am Coll Cardiol. 1993;21:432-441.
27. Ayanian JZ, Epstein AM. Differences in the use of procedures between women and men hospitalized for coronary artery disease. N Engl J Med. 1991;325:221-225.
28. Steingart RM, Packer M, Hamm P, et al. Sex differences in the management of coronary artery disease. N Engl J Med. 1991;325:226-230.
29. Tobin NJ, Wassertheil-Smoller S, Wexler JP, et al. Sex bias in considering coronary bypass surgery. Ann Intern Med. 1987;107:19-25.
30. Kinlay S, Leitch JW, Hardy DB, et al. Transtelephonic versus Holter monitoring for the diagnosis of palpitations. Pacing Clin Electrophysiol. 1995;18:932.
31. Fogel RI, Gest CR, Evans JJ, Prystowsky EN. Are event recorders useful and cost-effective in the diagnosis of palpitations, presyncope, and syncope? J Am Coll Cardiol. 1993;21:358, Abstract.
32. Shen WK, Holmes DR, Hammill SC. Transtelephonic monitoring: documentation of transient cardiac rhythm disturbances. Mayo Clin Proc. 1987;62:109-112.
33. Lindsay BD, Chung MK, Gamache C, et al. Therapeutic end points for the treatment of atrioventricular node reentrant tachycardia by catheter-guided radio-frequency current. J Am Coll Cardiol, 1993;22:733-740.
34. Moulton L, Scott J, Miller B, Moulton K. Improvement in quality of life following catheter ablation for supraventricular tachycardia. Pacing Clin Electrophysioi. 1993;16:909. Abstract.
35. Bygrave A, O'Farrell D, Grace A, et al, Patient satisfaction and residual symptoms following radiofrequency ablation for supraventricular tachycardia. Pacing Clin Electrophysiol. 1995;18:913. Abstract.
36. Shear MK, Kligfield P, Marshfield G, et al. Cardiac rate and rhythm in panic patients. Am J Psychiatry. 1987;144:633-637.
37. Jolley R, Lydiard RB, Assey ME, Usher BW, Barnwell WH, Ballenger JC. Cardiovascular status of panic disorder patients with and without prominent cardiac symptoms. Psychosomatics. 1992;33:81-84.
38. Taylor CB, Sheikh J, Agras WS, et al. Ambulatory heart rate changes in patients with panic attacks. Am J Psychiatry. 1986;143:478-482.
39. Lader M, Mathews A. Physiological changes during spontaneous panic attacks. J Psychosom Res, 1970;14:377-382.
40. Freedman RR, lanni P, Ettedgui E, Puthezhath N. Ambulatory monitoring of panic disorder. Arch Gen Psychiatry. 1985;42:244-248.
41. Orejarena LA, Vidaillet HJ, Nordstrom DL, et al. Incidence and clinical significance of paroxysmal supraventricular tachycardia in the general population. Circulation. 1994;90(suppl 1):1-282. Abstract.
42. Rostagno C, Paladini B, Taddei T, et al. Out-of-hospltal symptomatic supraventricular arrhythmias: epidemiologic aspects derived from 10 years experience of the Florence mobile coronary care unit. G Ital Cardiol. 1993;23:549-562.
43. Lesh MD. Interventional electrophysiology: state-of-the-art 1993. Am Heart J. 1993;126:686-698.
44. Bialy D, Lehmann MH, Schumacher DM, Steinman RT, Meissner MD. Hospitalization for arrhythmias in the United States: importance of atrial fibrillation. J Am Coll Cardiol. 1992;19:41. Abstract.
45. Stites HW, Thakur RK, Yee R, Klein GJ. Evaluation of an abbreviated protocol for catheter ablation of left free wall accessory pathways. Am J Cardiol. 1993;72:836-838,
46. Wang Y, Scheinman MM, Chien WW, Cohen TJ, Lesh MD, Griffin JC. Patients with supraventricular tachycardia presenting with aborted sudden death: incidence, mechanism and long-term follow-up. J Am Coll Cardiol. 1991;18:1711-1719.
47. Zardini M, Yee R, Thakur RK, Klein GJ, Risk of sudden arrhythmic death in the Wolff-Parkinson-White syndrome: current perspectives. Pacing Clin Electrophysiol. 1994;17:966-975.
48. Kinlay S, Leitch JW, Neil A, Chapman BL, Hardy DB, Fletcher PJ, Cardiac event recorders yield more diagnoses and are most cost-effective than 48-hour Holter monitoring in patients with palpitations, Ann intern Med. 1996;124:16-20.